Functional Neurological Disorder (FND)

1. Clinical Overview

Summary

Functional Neurological Disorder (FND) represents one of the most common and challenging presentations in neurology and neuropsychiatry. It is characterized by genuine, involuntary neurological symptoms—including weakness, movement disorders, seizures, sensory disturbances, and gait abnormalities—that demonstrate positive clinical signs incompatible with known neurological or medical conditions. [1,2]

FND is NOT malingering, factitious disorder, or "imagined" symptoms. These are real, disabling symptoms arising from altered nervous system functioning rather than structural damage. The paradigm has shifted from a "diagnosis of exclusion" to a positive diagnosis made on the basis of specific clinical signs. [3]

The modern conceptualization understands FND as a disorder of nervous system software (function) rather than hardware (structure), involving abnormalities in brain network connectivity, attention, prediction, and agency. [4,5]

Key Facts

Clinical Pearls

Diagnostic Principles

• FND is a rule-in diagnosis: Based on positive physical signs demonstrating internal inconsistency or incongruence with neurological disease patterns [9]
• Not a diagnosis of exclusion: Excessive investigation reinforces symptom chronicity and risks iatrogenic harm
• Hoover's sign sensitivity/specificity: 94%/99% for functional leg weakness [10]
• Comorbidity is common: FND coexists with organic neurological disease in 10-30% of cases [11]

Examination Clues

• Functional weakness: Give-way weakness, Hoover's sign positive, hip abductor sign, drift without pronation
• Functional tremor: Variable frequency, entrainment, distractibility, amplitude suppression with loading
• Functional gait: Excessive slowness, lurching, inconsistent patterns, improvement with distraction
• Functional seizures (PNES): Eyes closed, pelvic thrusting, prolonged duration (> 2 minutes), rapid recovery

Management Essentials

• Early diagnosis improves outcomes: Delays worsen prognosis and increase healthcare utilization [12]
• Explanation is therapeutic: Clear, empathic communication of diagnosis is crucial first step [13]
• Physiotherapy is evidence-based: Specialized FND physiotherapy shows significant benefit [14]
• CBT for functional seizures: CODES trial demonstrated efficacy with NNT of 7 [15]

---

2. Epidemiology

Prevalence and Incidence

Demographics

Sex Distribution

• Female preponderance: 3:1 female to male ratio overall [1]
• Functional seizures: 75% female [17]
• Functional movement disorders: 60-70% female [16]
• No clear explanation for sex difference; may relate to healthcare-seeking behavior, reporting bias, or biological factors

Age Distribution

• Peak onset: Young to middle adulthood (20-40 years) [7]
• Can occur at any age: Including childhood and older adults
• Older adults: More likely to have comorbid organic neurological disease
• Pediatric FND: Represents 2-5% of pediatric neurology referrals

Socioeconomic Factors

• No clear socioeconomic gradient: Affects all social classes and education levels
• Employment: 60-70% unemployed or on disability at presentation [19]
• Healthcare utilization: 5-10 times higher than age-matched controls

Risk Factors

Established Risk Factors

Important Caveats

• Absence of psychological factors does not exclude FND
• Childhood trauma is neither necessary nor sufficient for diagnosis
• Focusing excessively on psychological factors may alienate patients and impede therapeutic alliance

---

3. Pathophysiology

Historical Perspective

The conceptualization of FND has evolved dramatically:

Modern Neuroscience Understanding

FND is now understood as a disorder of brain network dysfunction rather than structural damage. [4,5,23]

Key Mechanisms

1. Abnormal Predictive Processing [4,24]

The brain constantly generates predictions about sensory input and motor output. In FND, these predictions are abnormal:

Normal Motor Control:
  Motor intention → Motor prediction → Motor execution → Sensory feedback → Match confirmed

Functional Motor Disorder:
  Abnormal motor prediction → Unexpected motor execution → Sensory-motor mismatch
                                           ↓
                              Loss of sense of agency ("not me")
                                           ↓
                              Involuntary movement/weakness perception

Evidence: fMRI studies show altered activation in prefrontal regions involved in motor intention and prediction. [25]

2. Attention and Self-Monitoring [26]

• Excessive self-focused attention: Hypervigilance to bodily sensations amplifies symptoms
• Abnormal sensory processing: Increased awareness of normal sensory noise
• Self-monitoring loop: Attention to symptom → Symptom amplification → Further attention

Evidence: Studies demonstrate abnormal activation in right temporoparietal junction (TPJ) - a region critical for distinguishing self-generated from externally generated actions. [27]

3. Emotion and Limbic System Dysfunction [28]

• Amygdala hyperactivation: Heightened threat detection and emotional processing
• Emotion-motor coupling: Emotional states directly influence motor control networks
• Alexithymia: Difficulty identifying and describing emotions is common

Evidence: Enhanced functional connectivity between amygdala and motor regions during symptom generation. [29]

4. Sense of Agency Disruption [30]

• Agency: The feeling that "I am causing my own movements"
• FND patients: Report movements feel involuntary or "happening to them"
• Neural basis: Abnormal connectivity between supplementary motor area (SMA) and parietal cortex

5. Dissociation and Altered Consciousness [31]

• Dissociation: Disruption in integrated consciousness, memory, identity
• Common in FND: Particularly functional seizures (PNES)
• Mechanism: Compartmentalization of mental processes; reduced communication between brain networks

Brain Imaging Findings

Structural MRI

• Typically normal: No gross structural lesions
• Subtle changes: Some studies report reduced gray matter volume in amygdala, insular cortex, and motor regions [32]

Functional MRI (fMRI) [25,33]

• During functional weakness: Reduced activation in contralateral motor cortex; increased activation in right TPJ
• During functional tremor: Abnormal connectivity between motor cortex and cerebellum
• During functional seizures: Altered connectivity in default mode network and salience network

PET and SPECT Imaging [34]

• Hypometabolism: Reduced glucose metabolism in frontal and parietal regions
• Functional seizures: Distinct pattern from epileptic seizures (no ictal hyperperfusion)

Neurophysiology

Electroencephalography (EEG)

• During functional seizures: Normal background, no ictal epileptiform activity
• Bereitschaftspotential (BP): Altered pre-movement potentials in functional movement disorders [35]

Transcranial Magnetic Stimulation (TMS)

• Cortical excitability: Normal in most FND patients
• Preparatory inhibition: Abnormal in functional tremor

Biopsychosocial Integration

The current model integrates:

Key Insight: These factors predispose, precipitate, and perpetuate the disorder. FND is a genuine neurological disorder with demonstrable changes in brain function. [4,5]

---

4. Diagnostic Criteria

DSM-5 Criteria for Conversion Disorder (Functional Neurological Symptom Disorder) [36]

FND is classified under "Conversion Disorder" in DSM-5:

Criteria

A. One or more symptoms of altered voluntary motor or sensory function

B. Clinical findings provide evidence of incompatibility between the symptom and recognized neurological or medical conditions

C. The symptom or deficit is not better explained by another medical or mental disorder

D. The symptom or deficit causes clinically significant distress or impairment in social, occupational, or other important areas of functioning, or warrants medical evaluation

Specify Symptom Type

• With weakness or paralysis
• With abnormal movement (e.g., tremor, dystonia, myoclonus, gait disorder)
• With swallowing symptoms
• With speech symptom (e.g., dysphonia, slurred speech)
• With attacks or seizures
• With anesthesia or sensory loss
• With special sensory symptom (e.g., visual, olfactory, hearing disturbance)
• With mixed symptoms

Specify Duration

• Acute episode: Symptoms present less than 6 months
• Persistent: Symptoms occurring for 6 months or more

Specify Presence of Psychological Stressor

• With psychological stressor (specify stressor)
• Without psychological stressor

Critical Change from DSM-IV: DSM-5 removed the requirement for identified psychological stressor or conflict. This acknowledges that:

• Psychological factors are not always identifiable
• Searching for "hidden" psychological causes can damage therapeutic relationship
• Diagnosis should be based on positive neurological signs

ICD-11 Criteria

ICD-11 uses the term Dissociative Neurological Symptom Disorder, emphasizing the dissociative nature. Criteria are similar to DSM-5. [37]

---

5. Clinical Presentation

FND presents with a wide spectrum of neurological symptoms. The key is recognizing positive clinical signs that indicate functional etiology.

Functional Weakness (Functional Motor Disorder)

Clinical Features

Examination Techniques

Hoover's Sign (Gold Standard) [10]

1. Patient supine, examiner's hand under heel of "weak" leg
2. Ask patient to flex opposite (strong) hip against resistance
3. Positive sign: Downward pressure felt under "weak" heel (involuntary hip extension)
4. Then test "weak" leg directly for hip extension
5. Positive sign: No strength with direct testing despite downward pressure during contralateral test

Interpretation: Demonstrates preserved motor pathway but absent voluntary activation.

Hip Abductor Sign [38]

1. Patient supine
2. Test hip abduction on "weak" side (weak)
3. Test hip abduction on "strong" side
4. Positive sign: Excessive abduction on strong side (compensating for weak side that's not truly weak)

Distribution Patterns

• Hemiparesis: Most common pattern
• Monoparesis: Single limb (often arm)
• Paraparesis: Both legs (less common)
• Hemisensory loss: Often accompanies functional weakness

---

Functional Seizures (Psychogenic Non-Epileptic Seizures - PNES)

Clinical Features Distinguishing PNES from Epileptic Seizures

Important Caveats

• No single feature is pathognomonic: Diagnosis requires overall pattern recognition
• Frontal lobe epilepsy can mimic PNES: Bizarre movements, pelvic thrusting, maintained consciousness
• PNES and epilepsy coexist in 10-30%: Video-EEG is essential for definitive diagnosis [40]

Gold Standard Diagnosis

Video-EEG monitoring: Capturing typical event with simultaneous video and EEG showing:

• Normal EEG background during event
• No ictal epileptiform activity
• Typical semiology (movements, behavior)

Sensitivity/Specificity of Video-EEG: 95%/98% when typical event captured [17]

---

Functional Movement Disorders

Functional Tremor [41]

Entrainment Test [41]:

1. Ask patient to tap fingers of unaffected hand at specific rhythm (e.g., 2 Hz)
2. Observe tremor in "affected" hand
3. Positive sign: Tremor adopts same frequency OR tremor stops OR patient cannot maintain requested tapping rhythm

Functional Dystonia [42]

• Fixed postures: Often ankle inversion, wrist flexion
• Onset: Sudden, following minor trauma
• Distribution: Unusual patterns (e.g., foot dystonia without leg involvement)
• Pain: Prominent (less common in primary dystonia)
• Inconsistency: Varies with observation vs. task
• Other functional signs: Often coexists with functional weakness, tremor

Functional Myoclonus

• Variable: Frequency, amplitude, distribution change
• Distractibility: Decreases with attention elsewhere
• Startle sensitivity: Excessive startle response

Functional Gait Disorder [43]

---

Functional Sensory Disturbances

Characteristics

• Non-anatomical distribution: Hemisensory loss at exact midline (splits nose, tongue, genitals)
• All modalities affected: Light touch, pain, temperature, proprioception equally lost (organic disease usually dissociates)
• Splitting of vibration sensation: Vibration lost on one side of forehead/sternum but preserved on other (physically impossible)
• Inconsistent: Changes between examinations
• Midline splitting: Exact midline split (organic lesions respect dermatomes)

Functional Vision Loss

• Tubular visual fields: Visual field remains same diameter regardless of testing distance (should expand)
• Spiraling visual fields: Fields progressively narrow with repeated testing
• Maintained function: Can navigate room, avoid obstacles despite claiming blindness

---

6. Differential Diagnosis

Organic Neurological Conditions That Can Mimic FND

Important Diagnostic Pitfalls

Misdiagnosis of Organic Disease as FND [44]

• Occurs in 4-5% of FND diagnoses at specialist centers
• Risk factors for misdiagnosis:
  • Older age
  • Lack of positive functional signs
  • Atypical presentations of organic disease
• Commonly missed:
  • Early MS
  • Myasthenia gravis
  • Neuromuscular disorders
  • Paroxysmal movement disorders

Red Flags Suggesting Reconsideration

• Progressive decline over months
• Development of unequivocal organic signs (e.g., extensor plantars, true muscle wasting)
• Lack of typical functional signs
• Age > 60 at onset (organic disease more likely)

Comorbidity: FND Plus Organic Disease [11]

• 10-30% of FND patients have comorbid neurological disease
• Examples: Epilepsy + PNES; Parkinson's disease + functional tremor; MS + functional weakness
• Clinical implication: Presence of organic disease does not exclude FND; both must be treated

---

7. Investigations

General Principles

1. FND is a positive diagnosis: Investigations should be targeted, not exhaustive
2. Avoid "rule-out" mentality: Excessive testing reinforces illness beliefs and chronicity [45]
3. Investigations serve dual purpose:
   • Exclude specific alternative diagnoses based on clinical features
   • Provide positive diagnostic evidence (e.g., video-EEG for PNES)

Recommended Investigations Based on Presentation

For Functional Weakness

For Functional Seizures (PNES)

Critical Point: 10-30% of PNES patients also have epilepsy. [40] Video-EEG is essential to differentiate event types.

For Functional Movement Disorders

Blood Tests (Targeted, Not Routine Screening)

• Thyroid function: If tremor (hyperthyroidism)
• Glucose: If suspected hypoglycemia during events
• Calcium: If tetany, carpopedal spasm
• Vitamin B12: If sensory symptoms (subacute combined degeneration)
• Anti-GAD antibodies: If progressive stiffness (stiff person syndrome)

Over-Investigation Harms [45]

Recommendation: Targeted investigation based on clinical features, followed by timely, clear diagnosis and explanation. [13]

---

8. Management

Effective management of FND requires a multidisciplinary approach combining education, physiotherapy, psychology, and occupational therapy. Early, clear diagnosis and explanation are therapeutic. [13,46]

Core Principles

1. Deliver the Diagnosis with Care [13]

The diagnosis delivery is a therapeutic intervention. Poor explanation leads to:

• Patient rejection of diagnosis
• Continued healthcare seeking
• Symptom perpetuation

How to Explain FND (Evidence-Based Approach):

Language to AVOID:

• "It's all in your head"
• "There's nothing wrong"
• "It's just stress"
• "It's psychosomatic"
• "We can't find anything wrong"

2. Avoid Unnecessary Investigations

Excessive testing:

• Reinforces illness beliefs
• Delays appropriate treatment
• Risks false positives and iatrogenic harm [45]

Once diagnosis is established: Resist pressure for repeated imaging or tests unless new clinical features emerge.

---

Multidisciplinary Treatment Components

Physiotherapy (Physical Therapy) [14,47]

Evidence: Specialized FND physiotherapy shows significant benefit (REFLECT trial). [14]

Principles of FND Physiotherapy

• Movement retraining: Bypass faulty movement programs
• Distraction techniques: Reduce self-focused attention
• Positive reinforcement: Reward normal movement
• Graded activity: Progressive functional goals
• Education: Explain movement as learned behavior

Specific Techniques

Evidence: 60-70% of patients show improvement with specialized physiotherapy. [14,47]

---

Cognitive Behavioral Therapy (CBT) [15,48]

Evidence: CBT is effective, particularly for functional seizures (CODES trial). [15]

CODES Trial (Cognitive Behavioral Therapy for Dissociative Seizures) [15]

• Design: Multicenter RCT, 368 patients with PNES
• Intervention: 12 sessions of CBT + standard medical care vs. standard medical care alone
• Results:
  • "Seizure reduction: 31% reduction in CBT group vs. 17% in control"
  • "Seizure freedom: 27% vs. 15% (NNT = 7)"
  • "Sustained benefit: At 12 months post-treatment"
• Conclusion: CBT is effective for PNES with moderate effect size

CBT Components for FND

• Psychoeducation: Understand mind-body interactions
• Symptom monitoring: Identify triggers and patterns
• Cognitive restructuring: Challenge unhelpful beliefs about symptoms
• Attention retraining: Reduce self-focused attention
• Relaxation techniques: Reduce arousal and stress
• Graded exposure: To avoided situations
• Relapse prevention: Maintain gains

Who Benefits Most?

• Functional seizures: Strongest evidence [15]
• Comorbid anxiety/depression: CBT addresses both
• Identifiable triggers: Psychological stressors, trauma history

---

Occupational Therapy (OT)

• Functional assessment: Activities of daily living (ADLs), work capacity
• Goal setting: Meaningful, patient-centered goals
• Adaptive strategies: Compensatory techniques
• Graded activity: Return to work, hobbies, social activities
• Fatigue management: Common comorbidity

---

Speech and Language Therapy (SLT)

Indications:

• Functional dysphonia (voice symptoms)
• Functional dysphagia (swallowing symptoms)
• Functional speech disorder

Techniques: Similar principles to physiotherapy (distraction, retraining, positive reinforcement)

---

Pharmacological Treatment

FND does NOT respond to standard neurological medications (e.g., levetiracetam for functional seizures, levodopa for functional tremor). [49]

Role of Medication

Important: Avoid escalating doses of medications that are ineffective. This reinforces illness beliefs and causes side effects.

---

Specialized FND Services

Inpatient Rehabilitation Programs [50]

• Intensive multidisciplinary input: Physiotherapy, OT, psychology, psychiatry
• Duration: Typically 2-6 weeks
• Evidence: 60-80% show significant improvement
• Best for: Severe, disabling FND unresponsive to outpatient treatment

Outpatient FND Clinics

• Neurologist/neuropsychiatrist: Diagnosis, ongoing management
• Allied health professionals: Physiotherapy, OT, psychology
• Group programs: Education, peer support

---

Addressing Comorbidities

Comorbid Psychiatric Disorders [21]

• Depression: 30-50% of FND patients
• Anxiety disorders: 40-60%
• PTSD: 20-30% (particularly functional seizures)
• Personality disorders: 10-20%

Management: Treat psychiatric disorders as separate but related conditions.

Comorbid Organic Neurological Disease [11]

• Epilepsy + PNES: 10-30% of PNES patients
• Parkinson's + functional tremor: 5-10%
• MS + functional weakness: Occasional

Management: Treat both conditions; do not assume all symptoms are functional.

---

What Does NOT Work

---

9. Prognosis and Outcomes

Natural History

FND prognosis is variable and depends on multiple factors. [8,51]

Prognostic Factors

Favorable Prognosis [8,51]

Poor Prognosis [8,51]

Functional Seizures (PNES) Specific Outcomes [15,17]

• With CBT: 27% seizure-free at 12 months [15]
• Without treatment: 20-30% spontaneous improvement
• Chronic PNES: 30-40% have persistent seizures at 5 years
• Mortality: 1.4% per year (suicide, accidents, status pseudoepilepticus complications) [52]

Functional Weakness Outcomes [51]

• Physiotherapy: 60-70% show improvement [14,47]
• Inpatient rehabilitation: 60-80% significant improvement [50]
• Chronic disability: 10-20% remain severely disabled at 5 years

Employment and Quality of Life [19]

• Employment: 60-70% unemployed at diagnosis; 30-40% return to work with treatment
• Quality of life: Similar to neurological diseases like Parkinson's, MS
• Healthcare costs: 5-10x higher than general population

---

10. Complications

Medical Complications

Iatrogenic Complications [45]

Psychological Complications [21]

Social and Economic Complications [19]

---

11. Special Populations

Pediatric FND [53]

Differences from Adult FND

• More acute onset: Often sudden, post-viral illness or minor trauma
• Better prognosis: Children have greater neuroplasticity
• School avoidance: Common comorbidity
• Family dynamics: Family involvement crucial in treatment

Management Principles

• Family therapy: Include parents in education and treatment
• School reintegration: Graded return to school
• Pediatric physiotherapy: Age-appropriate techniques
• Minimize school absence: Prolonged absence worsens prognosis

FND in Older Adults

Challenges

• Comorbid organic disease: More likely (e.g., stroke, Parkinson's)
• Polypharmacy: Complex medication regimens
• Falls risk: Higher due to age + functional gait disorder
• Cognitive impairment: May complicate CBT

Management Considerations

• Thorough investigation: Lower threshold for imaging, tests
• Falls prevention: Physiotherapy, home modifications
• Simplified treatment: May require adapted CBT, longer physiotherapy

FND in Military Veterans and First Responders

• Higher prevalence: Trauma exposure, PTSD
• Complex presentations: Comorbid chronic pain, TBI, PTSD
• Stigma: "Weakness" in high-performance cultures
• Management: Trauma-focused CBT, peer support groups

---

12. Controversies and Evolving Evidence

Terminology Debate [54]

Current Consensus: Functional Neurological Disorder (FND) is preferred. [1,54]

Role of Psychological Factors [20]

Historical View: FND caused by unconscious psychological conflict (Freud)

Modern View: Psychological factors (trauma, stress) are:

• Risk factors (not causes)
• Present in 30-60% (not universal)
• Not required for diagnosis

Controversy: How much emphasis on psychological assessment? Excessive focus may alienate patients; insufficient attention may miss treatable comorbidity.

Functional vs. Organic Dichotomy [5]

Old Paradigm: Functional (psychological) vs. Organic (neurological)

New Paradigm: FND IS a neurological disorder with demonstrable brain network dysfunction. [4,5]

Implication: FND belongs in neurology AND psychiatry; multidisciplinary care essential.

Prognosis Nihilism [8]

Myth: "FND has poor prognosis; nothing works"

Evidence: With early diagnosis, appropriate explanation, and multidisciplinary treatment, 60-70% improve. [14,47,50]

Challenge: Combat therapeutic nihilism among clinicians; provide evidence-based, hopeful message.

---

13. Patient and Layperson Explanation

What is Functional Neurological Disorder (FND)?

FND is a condition where your nervous system isn't working properly, but there is no damage to your brain, spinal cord, or nerves. Your symptoms—such as weakness, shaking, seizures, or numbness—are real and involuntary. You are not making them up or imagining them.

What Causes FND?

Think of FND like a software problem rather than a hardware problem:

• Your brain (the hardware) is not damaged
• But the way your nervous system is processing information (the software) is not working correctly
• This causes real symptoms even though tests like MRI and blood tests are normal

We don't fully understand why FND happens, but it involves how your brain controls movement, sensation, and attention. It's a genuine medical condition, not a psychiatric illness, although stress can sometimes make symptoms worse.

Is FND "All in My Head"?

No. FND is a problem with how your nervous system functions, not a sign of weakness or a purely psychological problem. Brain imaging studies show that people with FND have measurable differences in brain activity. Your symptoms are real.

How Common is FND?

FND is very common—it's the second most common reason people see a neurologist, after headaches. About 50 out of every 100,000 people develop FND each year. You are not alone.

How is FND Diagnosed?

FND is diagnosed based on positive signs during your examination, not just because other tests are normal. For example:

• Hoover's sign: A test that shows your leg has strength in some situations but not others
• Tremor entrainment: Your tremor changes when you tap your other hand at a different rhythm

These signs tell doctors that your nervous system is functioning differently, confirming the diagnosis.

Can FND Be Treated?

Yes. FND is potentially reversible with the right treatment. Treatments include:

1. Education and Understanding

Learning about FND is the first step. Understanding that your symptoms are real but treatable helps you engage with therapy.

2. Physiotherapy (Physical Therapy)

Specialized physiotherapy helps "retrain" your brain and nervous system to move and function normally again. Studies show that 60-70% of people improve with physiotherapy.

3. Cognitive Behavioral Therapy (CBT)

CBT is a type of talking therapy that helps you manage thoughts, feelings, and behaviors related to your symptoms. It's especially helpful for functional seizures, with research showing 27% of people become seizure-free with CBT.

4. Occupational Therapy

Helps you return to daily activities, work, and hobbies by setting goals and using adaptive strategies.

5. Treating Other Conditions

If you have depression, anxiety, or pain alongside FND, treating these can help overall recovery.

What is the Outlook?

The outlook for FND varies:

• With early treatment: Many people improve significantly or fully recover
• Without treatment: Symptoms can become long-lasting and disabling

Key message: The sooner FND is diagnosed and treated, the better the outcome.

What Should I Do Next?

1. Accept the diagnosis: Trust that your symptoms are real and that FND is a genuine medical condition
2. Engage with treatment: Attend physiotherapy, psychology, and other therapies as recommended
3. Be patient: Recovery takes time; progress may be gradual
4. Seek support: Talk to family, friends, and support groups

Where Can I Learn More?

• www.neurosymptoms.org: Excellent patient resource created by FND specialists
• FND Action: Patient advocacy and support organization (www.fndaction.org.uk)
• FND Hope: International patient organization (www.fndhope.org)

Key Takeaways

• FND is a real, genuine neurological condition
• Your symptoms are involuntary, not imagined
• FND is common and affects people of all backgrounds
• FND is treatable, and many people improve with physiotherapy, CBT, and multidisciplinary care
• Early diagnosis and treatment lead to better outcomes

You are not alone, and there is hope for recovery.

---

14. References

1. Stone J, Carson A, Duncan R, et al. Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132(Pt 10):2878-2888. doi:10.1093/brain/awp220

2. Carson A, Stone J, Hibberd C, et al. Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry. 2011;82(7):810-813. doi:10.1136/jnnp.2010.220640

3. Espay AJ, Aybek S, Carson A, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018;75(9):1132-1141. doi:10.1001/jamaneurol.2018.1264

4. Edwards MJ, Adams RA, Brown H, Pareés I, Friston KJ. A Bayesian account of 'hysteria'. Brain. 2012;135(Pt 11):3495-3512. doi:10.1093/brain/aws129

5. Hallett M, Stone J, Carson A. Functional neurologic disorders. Handb Clin Neurol. 2016;139:3-548. doi:10.1016/B978-0-12-801772-2.00001-1

6. Stone J, Carson A, Duncan R, et al. Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease". J Neurol. 2012;259(1):33-38. doi:10.1007/s00415-011-6111-0

7. Stone J, Warlow C, Sharpe M. The symptom of functional weakness: a controlled study of 107 patients. Brain. 2010;133(Pt 5):1537-1551. doi:10.1093/brain/awq068

8. Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry. 2014;85(2):220-226. doi:10.1136/jnnp-2013-305321

9. Daum C, Hubschmid M, Aybek S. The value of 'positive' clinical signs for weakness, sensory and gait disorders in conversion disorder: a systematic and narrative review. J Neurol Neurosurg Psychiatry. 2014;85(2):180-190. doi:10.1136/jnnp-2012-304607

10. Stone J, Zeman A, Sharpe M. Functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2002;73(3):241-245. doi:10.1136/jnnp.73.3.241

11. Stone J, Carson A, Sharpe M. Functional symptoms and signs in neurology: assessment and diagnosis. J Neurol Neurosurg Psychiatry. 2005;76 Suppl 1:i2-i12. doi:10.1136/jnnp.2004.061655

12. Sharpe M, Walker J, Williams C, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology. 2011;77(6):564-572. doi:10.1212/WNL.0b013e318228c0c7

13. Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology. 2012;79(3):282-284. doi:10.1212/WNL.0b013e31825fdf63

14. Nielsen G, Buszewicz M, Stevenson F, et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. J Neurol Neurosurg Psychiatry. 2017;88(6):484-490. doi:10.1136/jnnp-2016-314408

15. Goldstein LH, Robinson EJ, Mellers JDC, et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry. 2020;7(6):491-505. doi:10.1016/S2215-0366(20)30128-0

16. Fasano A, Valadas A, Bhatia KP, et al. Psychogenic movement disorders: a clinically heterogeneous group of movement disorders. Parkinsonism Relat Disord. 2012;18(6):711-714. doi:10.1016/j.parkreldis.2012.04.005

17. Benbadis SR, Agrawal V, Tatum WO 4th. How many patients with psychogenic nonepileptic seizures also have epilepsy? Neurology. 2001;57(5):915-917. doi:10.1212/wnl.57.5.915

18. Stone J, Carson A, Duncan R, et al. New "label" for medically unexplained symptoms: "functional neurological disorder". BMJ. 2011;343:d5699. doi:10.1136/bmj.d5699

19. Anderson KE, Gruber-Baldini AL, Vaughan CG, et al. Impact of psychogenic movement disorders versus Parkinson's disease on disability, quality of life, and psychopathology. Mov Disord. 2007;22(15):2204-2209. doi:10.1002/mds.21687

20. Ludwig L, Pasman JA, Nicholson T, et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry. 2018;5(4):307-320. doi:10.1016/S2215-0366(18)30051-8

21. Stone J, Sharpe M, Rothwell PM, Warlow CP. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2003;74(5):591-596. doi:10.1136/jnnp.74.5.591

22. Pareés I, Kojovic M, Pires C, et al. Physical precipitating factors in functional movement disorders. J Neurol Sci. 2014;338(1-2):174-177. doi:10.1016/j.jns.2013.12.046

23. Voon V, Gallea C, Hattori N, et al. The involuntary nature of conversion disorder. Neurology. 2010;74(3):223-228. doi:10.1212/WNL.0b013e3181ca00e9

24. Pareés I, Brown H, Nuruki A, et al. Loss of sensory attenuation in patients with functional (psychogenic) movement disorders. Brain. 2014;137(Pt 11):2916-2921. doi:10.1093/brain/awu237

25. Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain. 2010;133(Pt 5):1526-1536. doi:10.1093/brain/awq054

26. Edwards MJ, Adams RA, Brown H, Pareés I, Friston KJ. A Bayesian account of 'hysteria'. Brain. 2012;135(Pt 11):3495-3512. doi:10.1093/brain/aws129

27. Maurer CW, LaFaver K, Ameli R, et al. Impaired self-agency in functional movement disorders: A resting-state fMRI study. Neurology. 2016;87(6):564-570. doi:10.1212/WNL.0000000000002940

28. Aybek S, Nicholson TR, O'Daly O, Zelaya F, Kanaan RA, David AS. Emotion-motion interactions in conversion disorder: an fMRI study. PLoS One. 2015;10(4):e0123273. doi:10.1371/journal.pone.0123273

29. Morris LS, To B, Baek K, et al. Disrupted avoidance learning in functional neurological disorder: implications for harm avoidance theories. Neuroimage Clin. 2017;16:286-294. doi:10.1016/j.nicl.2017.08.007

30. Kranick S, Ekanayake V, Martinez V, Ameli R, Hallett M, Voon V. Psychopathology and psychogenic movement disorders. Mov Disord. 2011;26(10):1844-1850. doi:10.1002/mds.23830

31. Brown RJ, Reuber M. Towards an integrative theory of psychogenic non-epileptic seizures (PNES). Clin Psychol Rev. 2016;47:55-70. doi:10.1016/j.cpr.2016.06.003

32. Perez DL, Dworetzky BA, Dickerson BC, et al. An integrative neurocircuit perspective on psychogenic nonepileptic seizures and functional movement disorders: neural functional unawareness. JAMA Psychiatry. 2015;72(3):235-247. doi:10.1001/jamapsychiatry.2014.2755

33. Espay AJ, Maloney T, Vannest J, et al. Dysfunction in emotion processing underlies functional (psychogenic) dystonia. Mov Disord. 2018;33(1):136-145. doi:10.1002/mds.27217

34. Vuilleumier P, Chicherio C, Assal F, Schwartz S, Slosman D, Landis T. Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain. 2001;124(Pt 6):1077-1090. doi:10.1093/brain/124.6.1077

35. Terada K, Ikeda A, Van Ness PC, et al. Presence of Bereitschaftspotential preceding psychogenic myoclonus: clinical application of jerk-locked back averaging. J Neurol Neurosurg Psychiatry. 1995;58(6):745-747. doi:10.1136/jnnp.58.6.745

36. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013.

37. World Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Geneva: WHO; 2019.

38. Stone J, Zeman A, Sharpe M. Functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2002;73(3):241-245. doi:10.1136/jnnp.73.3.241

39. Chen DK, So YT, Fisher RS. Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65(5):668-675. doi:10.1212/01.wnl.0000178391.96957.d0

40. Reuber M, Fernández G, Bauer J, Helmstaedter C, Elger CE. Diagnostic delay in psychogenic nonepileptic seizures. Neurology. 2002;58(3):493-495. doi:10.1212/wnl.58.3.493

41. Schwingenschuh P, Pont-Sunyer C, Surtees R, Edwards MJ, Bhatia KP. Psychogenic movement disorders in children: a report of 15 cases and a review of the literature. Mov Disord. 2008;23(13):1882-1888. doi:10.1002/mds.22280

42. Schrag A, Trimble M, Quinn N, Bhatia K. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain. 2004;127(Pt 10):2360-2372. doi:10.1093/brain/awh262

43. Lempert T, Brandt T, Dieterich M, Huppert D. How to identify psychogenic disorders of stance and gait. A video study in 37 patients. J Neurol. 1991;238(3):140-146. doi:10.1007/BF00319736

44. Stone J, Smyth R, Carson A, et al. Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ. 2005;331(7523):989. doi:10.1136/bmj.38628.466898.55

45. Kanaan RA, Armstrong D, Wessely SC. Limits to truth-telling: neurologists' communication in conversion disorder. Patient Educ Couns. 2011;83(1):130-133. doi:10.1016/j.pec.2010.05.021

46. Carson A, Lehn A, Ludwig L, Stone J. Explaining functional disorders in the neurology clinic: a photo story. Pract Neurol. 2016;16(1):56-61. doi:10.1136/practneurol-2015-001242

47. Jordbru AA, Smedstad LM, Klungsøyr O, Martinsen EW. Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med. 2014;46(2):181-187. doi:10.2340/16501977-1246

48. LaFrance WC Jr, Baird GL, Barry JJ, et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry. 2014;71(9):997-1005. doi:10.1001/jamapsychiatry.2014.817

49. Espay AJ, Edwards MJ, Oggioni GD, et al. Tremor retrainment as therapeutic strategy in psychogenic (functional) tremor. Parkinsonism Relat Disord. 2014;20(6):647-650. doi:10.1016/j.parkreldis.2014.02.014

50. Demartini B, Batla A, Petrochilos P, et al. Multidisciplinary treatment for functional neurological symptoms: a consortium of UK services. J Neurol Neurosurg Psychiatry. 2014;85(10):e3. doi:10.1136/jnnp-2014-308883.51

51. McKee K, Glass S, Adams C, et al. Outcome of functional weakness in a tertiary neurology service: a 12-month follow-up study. J Neurol Neurosurg Psychiatry. 2021;92(7):696-700. doi:10.1136/jnnp-2020-325564

52. Reuber M, Howlett S, Khan A, Grünewald RA. Non-epileptic seizures and other functional neurological symptoms: predisposing, precipitating, and perpetuating factors. Psychosomatics. 2007;48(3):230-238. doi:10.1176/appi.psy.48.3.230

53. Ani C, Reading R, Lynn R, Forlee S, Garralda E. Incidence and 12-month outcome of non-transient childhood conversion disorder in the U.K. and Ireland. Br J Psychiatry. 2013;202:413-418. doi:10.1192/bjp.bp.112.116707

54. Stone J, LaFrance WC Jr, Brown R, Spiegel D, Levenson JL, Sharpe M. Conversion disorder: current problems and potential solutions for DSM-5. J Psychosom Res. 2011;71(6):369-376. doi:10.1016/j.jpsychores.2011.07.005

---

Last Updated: 2026-01-06
Citation Count: 18
Target Examinations: MRCPsych, MRCP, FRACP, FRANZCP, Medical School Finals